4:14 PM
 | 
Dec 27, 2017
 |  BC Extra  |  Company News

Management tracks: Vivus, Peregrine

Cardiovascular, metabolic and pulmonary company Vivus Inc. (NASDAQ:VVUS) said CEO Seth Fischer will step down. Thomas King, a director, will serve as interim CEO as the company seeks a permanent replacement. King was president and CEO of Alexza Pharmaceuticals Inc. until its 2016 acquisition by Grupo Ferrer Internacional S.A. (Barcelona, Spain).

Read the full 236 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >